secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0001493152-25-004025
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions partners with IVY Diagnostics to expand EU & Middle East drug screening market
--------------------------------------------------------------------------------

- Partnership with IVY Diagnostics Srl as key distributor for fingerprint drug screening in Europe and Middle East.
- IVY Diagnostics secured a tender for drug rehab programs across Italy using INBS' fingerprint drug screening technology.
- INBS' drug screening system undergoing trial with Turin police for roadside screening to test fingerprint-based method.
- Expansion to multiple countries: Romania, Hungary, Slovakia, Austria, Scandinavia, UAE, Saudi Arabia, Qatar.
- European drug screening market projected at $3.6B by 2030; Middle East & Africa at $432.7M (Grand View Research).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225004025/0001493152-25-004025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225004025/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer